Contenido principal
Ir al contenido principal
Menú de navegación
No hay
Navegación secundaria
disponible para el sitio actual.
Selector de idioma
Es
En
Español
English
Cerrar
Nuestros investigadores
Menú de navegación
No hay
Navegación secundaria
disponible para el sitio actual.
Menú de navegación
No hay
Navegación secundaria
disponible para el sitio actual.
Nuestros investigadores
Cerrar
Ruta de navegación
Estás en:
Investigacion
Nuestros investigadores
Curriculum de nuestros investigadores
Curriculum de nuestros investigadores - Investigacion
Detalle Profesor
Nuestros investigadores
Patricia Beorlegui Murillo
pbeorlegui@unav.es
Centro(s)
Área de Enfermería de Hospitalización
Clínica Universidad de Navarra Clínica Universidad de Navarra
Oncología Médica
Clínica Universidad de Navarra Clínica Universidad de Navarra
Grupos de investigación
Innovación para la Promoción de la Salud Familiar y Comunitaria
Publicaciones
Revistas (3)
Proyectos investigación
Fundaciones, PIUNA, Contratos(1)
Revistas
Autores:
Vera, R. (Autor de correspondencia); Otero, M. J.; de la Pena, F. A. ; et al.
Título:
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
Revista:
CLINICAL AND TRANSLATIONAL ONCOLOGY
ISSN:
1699-048X
Año:
2019
Vol.:
21
N°:
4
Págs.:
467 - 478
Enlace DADUN:
https://hdl.handle.net/10171/62161
Resumen
AimTo define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment.MethodsBy reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list.ResultsIn total, 68 recommendations arranged in five sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his/her family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity.ConclusionsIt is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication.
Autores:
Otero, M. J. (Autor de correspondencia); Vera, R.; Gonzalez-Perez, C.; et al.
Título:
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
Revista:
FARMACIA HOSPITALARIA
ISSN:
1130-6343
Año:
2018
Vol.:
42
N°:
6
Págs.:
261 - 268
Resumen
Objective: To define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment. Method: By reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list. Results: In total, 68 recommendations arranged in 5 sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity. Conclusions: It is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication.
Autores:
Valentí, Víctor
;
Hernández, José Luis
;
Beorlegui Murillo, Patricia
; et al.
Título:
Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy
Revista:
JOURNAL OF SURGICAL ONCOLOGY
ISSN:
0022-4790
Año:
2011
Vol.:
104
N°:
2
Págs.:
124-129
Resumen
Background: Significant tumor downstaging has been achieved in patients with localized gastric adenocarcinoma by preoperative chemoradiotherapy (ChRT) or induction chemotherapy (Ch). However the influence of ChRT and Ch on postoperative outcomes has not yet been clarified, with very few studies examining this issue. We retrospectively analyzed the efficacy in terms of pathological response and early postoperative complications of two protocols of preoperative ChRT and Ch for locally advanced gastric cancer. Methods: Between 2000 and 2008, 72 patients with operable locally advanced gastric cancer (cT3-4/N+) were treated with preoperative treatment: 1-patients receiving induction Ch or 2-neoadjuvant Ch followed by concurrent ChRT. Postoperative histopathological regression and surgical complications were investigated including variables related to patients, surgical variables, preoperative treatment, and tumor. Results: There were no differences in the incidence of complications between the ChRT and Ch groups (30.9% vs. 33.3%). The most frequent complications were nonspecific surgical complications (pneumonia [12.5%] and infection from intravenous catheters [9.7%]). Risk factors for complications were high-body mass index (BMI > 25 kg/m(2)) and extension of surgery to the pancreas and spleen. A major pathological response was observed in 33.3% of patients, being more frequent in the ChRT group (47.6% vs. 13.3%; chi(2), P = 0.0024).
Otros (PIUNA, fundaciones, contratos…)
Título:
Excelencia en Enfermería. Proyecto de Traslación del Conocimiento de la Enfermería de Familia, en la práctica clínica, en oncología
Código de expediente:
2018-03
Financiador:
UNIVERSIDAD DE NAVARRA
Convocatoria:
2020 Convocatoria PIUNA
Fecha de inicio:
01/09/2018
Fecha fin:
31/08/2021
Importe concedido:
5.800,00€
Oculto